Genes and Genomics p. 1431 - 1443 (2019)
Update date:2022-08-03
Topics:
El Majzoub, Rania
Fayyad-kazan, Mohammad
Nasr El Dine, Assaad
Makki, Rawan
Hamade, Eva
Grée, René
Hachem, Ali
Talhouk, Rabih
Fayyad-Kazan, Hussein
Badran, Bassam
Background: Breast cancer, the most commonly diagnosed malignancy in women, accounts for the highest cancer-related deaths worldwide. Triple negative breast cancer (TNBC), lacking the expression of estrogen, progesterone and HER2 receptors, has an aggressive clinical phenotype and is susceptible to chemotherapy but not to hormonal or targeted immunotherapy. In an attempt to identify potent and selective anti-TNBC agents, a set of thiosemicarbazone derivatives were screened for their cytotoxic activity against MDA-MB 231 breast cancer cell line. Methods: MTT assay was used to examine cell viability. P53 phosphorylation status, poly (ADP-ribose) polymerase (PARP) cleavage as well as Bcl2 and Bax protein levels were assessed by Western blot. Quantitative Real Time-PCR was carried out to characterize miRNAs expression levels. Results: Combining Cisplatin + thiosemicarbazone compound 4 showed potent anti-TNBC potential. Cisplatin + compound 4 significantly enhanced p53 phosphorylation, induced Bax amount, reduced Bcl2 protein levels, enhanced PARP cleavage and modulated miRNAs expression profile in TNBCs, with a particular overexpression of miR-125a-5p and miR-181a-5p. Intriguingly, miR-125a-5p and miR-181a-5p could significantly downregulate BCL2 expression by binding to their target sites in the 3′UTR. Conclusions: Collectively, our results demonstrate an anti-TNBC activity of Cisplatin + thiosemicarbazone compound 4 combination mediated via induction of apoptosis.
View Morewebsite:http://www.hybio.com.cn
Contact:+86 755 26588093
Address:No.9 Linkong West Street, Hengdian Street, Huangpi District, Wuhan City, China.
Contact:86-571-61063068
Address:LINAN
AllyChem Co., Ltd., Dalian, China(BBChem)
Contact:+86-411-62313318/62313328
Address:No.5 of Jinbin Road, Jinzhou New District, Dalian City, Liaoning Province, P.R.China
Sichuan Jisheng BioPharmaceutical Co., Ltd.
website:http://www.jisheng-peptide.com/
Contact:86-833-2598983
Address:No. 3, Jianye Road, High-tech Zone, Leshan City, Sichuan, China
Contact:86-21 60347964
Address:No.1304, West Meilong Road, Minhang District, Shanghai, China
Doi:10.1002/hlca.19510340318
(1951)Doi:10.1016/j.bmcl.2010.01.087
(2010)Doi:10.1007/s11171-005-0007-7
(2005)Doi:10.1021/acs.orglett.0c03929
(2021)Doi:10.1016/S0223-5234(02)01351-X
(2002)Doi:10.1021/jo026400h
(2003)